Found: 17
Select item for more details and to access through your institution.
Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group's clinical trial E3999.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00736-z
- By:
- Publication type:
- Article
Correction: Two-drug versus three-drug induction chemotherapy in pediatric acute myeloid leukemia: a randomized controlled trial.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Hematopoietic differentiation at single-cell resolution in NPM1-mutated AML.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00734-1
- By:
- Publication type:
- Article
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00732-3
- By:
- Publication type:
- Article
I-OPen: inferior outcomes of penta-refractory compared to penta-exposed multiple myeloma patients.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00733-2
- By:
- Publication type:
- Article
The prognostic value of the MASS in a multi-center cohort of patients with newly diagnosed multiple myeloma.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00731-4
- By:
- Publication type:
- Article
Comparison of outcomes for HLA-matched sibling and haplo-identical donors in Myelodysplastic syndromes: report from the chronic malignancies working party of EBMT.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00729-y
- By:
- Publication type:
- Article
Paraskeletal and extramedullary plasmacytomas in multiple myeloma at diagnosis and at first relapse: 50-years of experience from an academic institution.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00730-5
- By:
- Publication type:
- Article
Two-drug versus three-drug induction chemotherapy in pediatric acute myeloid leukemia: a randomized controlled trial.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00726-1
- By:
- Publication type:
- Article
Smoldering multiple myeloma current treatment algorithms.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00719-0
- By:
- Publication type:
- Article
R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00723-4
- By:
- Publication type:
- Article
Myelodysplastic syndromes with del(5q): A real-life study of determinants of long-term outcomes and response to lenalidomide.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00724-3
- By:
- Publication type:
- Article
Comparison of two free light chain assays: performance of the involved free light chain ratio and implications for diagnosis of multiple myeloma.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00722-5
- By:
- Publication type:
- Article
Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00721-6
- By:
- Publication type:
- Article
Iopofosine I-131 treatment in late-line patients with relapsed/refractory multiple myeloma post anti-BCMA immunotherapy.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00725-2
- By:
- Publication type:
- Article
High response rates with single-agent belantamab mafodotin in relapsed systemic AL amyloidosis.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00717-2
- By:
- Publication type:
- Article
Optical genome mapping refines cytogenetic diagnostics, prognostic stratification and provides new molecular insights in adult MDS/AML patients.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00718-1
- By:
- Publication type:
- Article